<!DOCTYPE HTML>
<html lang="en">

<head>
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

  <title>Honglei Zhou</title>

  <meta name="author" content="Honglei Zhou">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="shortcut icon" href="images/HongleiZhou.png" type="image/x-icon">
  <link rel="stylesheet" type="text/css" href="stylesheet.css">

</head>

<body>
  <table
    style="width:100%;max-width:800px;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;">
    <tbody>
      <tr style="padding:0px">
        <td style="padding:0px">
          <table
            style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;">
            <tbody>
              <tr style="padding:0px">
                <td style="padding:2.5%;width:63%;vertical-align:middle">
                  <p class="name" style="text-align: center;">
                    Honglei Zhou
                  </p>
                  <p>
                    I'm a staff software engineer in St Jude Children's Research Hospital. Before I joined St Jude, I was a research assistant professor and senior software engineer at <a href="http://www.jsph.org.cn/gjb.htm"
                      target="_blank">Jiangsu Province Hospital</a> in Nanjing, where my primary focus is
                    on developing bioinformatics analysis platforms, conducting research data analysis, and
                    collaborating with physicians to address real-world challenges.
                  </p>
                  <p>
                    Before I joined Jiangsu Province Hospital, I worked as senior software engineer in <a
                      href="https://www.progress.com/marklogic" target="_blank">MarkLogic</a> in San Mateo, where I
                    mainly involved in developing an AWS Spot Fleet-based
                    MarkLogic DB SaaS service.
                  </p>
                  <p>
                    I also have sereral years of experience in Start-up companies. From 2022 to 2024, I worked as
                    part-time software engineer
                    in <a href="https://paigo.tech/" target="_blank">Paigo</a> to design and develop the Paigo backend
                    customer service API, and implement
                    frontend dashboard feature.
                    From 2018 to 2020, I joined Bliss Motors as a founding member, working on the full development stack
                    of <a href="https://www.facebook.com/blissleaseusa?_rdr" target="_blank">Bliss Motors' </a>services
                    and creating a chatbot named <a href="images/telleai.png" target="_blank">Telle Chat</a>.
                    In 2017, I worked as project manager in a next-generation sequencing company named <a
                      href="https://www.cd-genomics.com/" target="_blank">CD Genomics</a>.
                  </p>
                  <p style="text-align:center">
                    <a href="mailto:uchzhou@gmail.com" target="_blank">Email</a> &nbsp;/&nbsp;
                    <a href="data/HongleiZhou-cv.pdf" target="_blank">CV</a> &nbsp;/&nbsp;
                    <a href="https://scholar.google.com/citations?user=dlvpBe0AAAAJ&hl=en" target="_blank">Google
                      Scholar</a>
                    &nbsp;/&nbsp;
                    <a href="https://github.com/Honglei-Zhou/" target="_blank">Github</a>
                  </p>
                </td>
                <td style="padding:3%;width:40%;max-width:40%">
                  <a href="images/HongleiZhou.png" target="_blank"><img
                      style="width:100%;max-width:100%;object-fit: cover;" alt="profile photo"
                      src="images/HongleiZhou.png" class="hoverZoomLink"></a>
                </td>
              </tr>
            </tbody>
          </table>
          <table
            style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;">
            <tbody>
              <tr>
                <td style="padding:10px 20px 10px 20px;width:100%;vertical-align:middle">
                  <h2>Education</h2>
                  <p>
                    I earned my Master’s degree in Computer Science from <a href="https://masters.cs.uchicago.edu/"
                      target="_blank">the
                      University of Chicago</a> in 2018.
                    Prior to that, I completed my Ph.D. study in Biochemistry and Molecular Biology at the <a
                      href="https://cm.jefferson.edu/" target="_blank">Computational Medicine Center of Thomas Jefferson
                      University</a>,
                    under the supervision of Prof. Isidore Rigoutsos.
                    I received my Bachelor’s degree in Biology from <a href="https://www.whu.edu.cn/"
                      target="_blank">Wuhan
                      University</a> in 2010.
                  </p>
                </td>
              </tr>
              <tr>
                <td style="padding:10px 20px 10px 20px;width:100%;vertical-align:middle">
                  <h2>Work Experience</h2>
                  <p>
                    I have worked on multiple projects in both academia and industry, as listed below.
                  </p>
                </td>
              </tr>
            </tbody>
          </table>
          <table
            style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;">
            <tbody>

              <tr>
                <td style="padding:20px;width:25%;vertical-align:middle">
                  <a href="images/ApplicationPlatform.png" target="_blank">
                    <img src="images/ApplicationPlatform.png" alt="b3do" width="160" style="border-style: none">
                  </a>
                </td>
                <td width="75%" valign="middle">
                  <span class="papertitle"><a href="images/bioinformatics.png" target="_blank">Bioinformatics Analysis
                      Platform (Jiangsu Province Hospital,2021-2024)</a></span>
                  <br>
                  <Strong>Tech stack: </Strong>
                  R, Python, Flask, JavaScript, Vue.js, OpenStack, Docker, cAdvisor, Graphite
                  <p>We developed a bioinformatics analysis platform with an intuitive dashboard, allowing scientists to
                    conduct data analysis without needing to write code.
                  </p>
                </td>
              </tr>

              <tr>
                <td style="padding:20px;width:25%;vertical-align:middle">
                  <a href="images/PaigoBusiness.png" target="_blank">
                    <img src="images/PaigoBusiness.png" alt="b3do" width="160" style="border-style: none">
                  </a>
                </td>
                <td width="75%" valign="middle">
                  <span class="papertitle"><a href="images/Paigo.png" target="_blank">Paigo SaaS Billing
                      (Paigo,2022-2024)</a></span>
                  <br>
                  <Strong>Tech stack: </Strong>
                  Kubernetes, Typescript, NestJS, Redis, BullMQ
                  <p>Paigo features an agent that collects resource metrics from clients, and it also supports clients
                    sending resource metrics via REST APIs.
                    The platform provides a dashboard where clients can define resource units used for billing their
                    customers.
                  </p>
                </td>
              </tr>

              <tr>
                <td style="padding:20px;width:25%;vertical-align:middle">
                  <a href="images/MarkLogic.png" target="_blank">
                    <img src="images/MarkLogic.png" alt="b3do" width="160" style="border-style: none">
                  </a>
                </td>
                <td width="75%" valign="middle">
                  <span class="papertitle"><a href="images/MarkLogic.png" target="_blank">Spot Fleet Option for
                      provisioning MarkLogic Cluster on AWS (MarkLogic,2020-2021)</a></span>
                  <br>
                  <Strong>Tech stack: </Strong>
                  Python, AWS SDK, Atlassian
                  <p>To reduce costs while still meeting client service-level agreements, I explored using AWS Spot
                    Fleets as a more cost-effective alternative for clusters.
                  </p>
                </td>
              </tr>

              <tr>
                <td style="padding:20px;width:25%;vertical-align:middle">
                  <a href="images/telleai.png" target="_blank">
                    <img src="images/telleai.png" alt="b3do" width="160" style="border-style: none">
                  </a>
                </td>
                <td width="75%" valign="middle">
                  <span class="papertitle"><a href="images/Chatbot.png" target="_blank">Bliss Motors Chatbot
                      SaaS (Blis Motors,2018-2020)</a></span>
                  <br>
                  <Strong>Tech stack: </Strong>
                  JavaScript, Vue.js, HTML/CSS,
                  Python, scrapy, scrapy-redis, PostgreSQL, MongoDB, Redis, AWS,
                  Django, Django Rest-Framework, OAuth, Twilio, Ejabbered
                  <p>Our chatbot has a frontend built using JavaScript with the Vue.js framework, allowing it to be
                    embedded in the website as an iframe.
                    The backend consists of multiple microservices that handle chat functionality and other services.
                  </p>
                </td>
              </tr>

              <tr>
                <td style="padding:20px;width:25%;vertical-align:middle">
                  <a href="images/JobMonitor.png" target="_blank">
                    <img src="images/JobMonitor.png" alt="b3do" width="160" style="border-style: none">
                  </a>
                </td>
                <td width="75%" valign="middle">
                  <span class="papertitle"><a href="images/JobMonitor.png" target="_blank">Job Level Monitoring
                      System (The University of Chicago,2018)</a></span>
                  <br>
                  <Strong>Tech stack: </Strong>
                  Python, PostgresSQL, cAdvisor, STATSD, Graphite
                  <p>We implemented a job-level monitoring system within the platform in HPC cluster.
                    This system monitors key metrics—such as CPU usage, memory, I/O, and network activity—at the job
                    level, as each job runs within a container.
                  </p>

                </td>
              </tr>

            </tbody>
          </table>

          <table
            style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;">
            <tbody>
              <tr>
                <td style="padding:10px 20px 10px 20px;width:100%;vertical-align:middle">
                  <h2>Research Experience</h2>
                  <p>
                    I have also contributed to several research projects on diseases, with the findings published in
                    peer-reviewed
                    journals as listed below.
                  </p>
                  <p>
                    1. Ji W#, Zhou H#, Liang W#, Zhang W, Gong B, Yin T, Chu J, Zhuang J, Zhang J, Luo Y, Liu Y, Gao J,
                    Yin Y. SSK1-Loaded Neurotransmitter-Derived Nanoparticles for Alzheimer's Disease Therapy via
                    Clearance of Senescent Cells. Small. 2024 Mar
                  </p>
                  <p>2. Lei Li, Yinjiao Fei, Tianfu Dong, Yuxin Song, Xiu Chen, Heda Zhang, Honglei Zhou*, Mingxing
                    Liang*, Jinhai Tang*,IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer,
                    International Immunopharmacology, 2024 May
                  </p>
                  <p>3. Shao X, Yang D, Shan L, Yan X, Xu D, Li L, Sun Y, Yu Q, Zhou H*, Ding Y*, Tang J*. TH-4000, a
                    hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+
                    breast cancer. Arch Toxicol. 2024 Jan
                  </p>
                  <p>4. Chu J, Hu H, Xu W, Lu X, Zhou H, Hao M, Wang L, Li S, Ji W, Li G, Luo Y, Gao J, Huang D, Liu Y, Yin Y. 
                    Top-down engineered micron-cell derived nanovesicles encapsulating curcumin targeting the 3R strategy 
                    (remove, remodel, repair) for Alzheimer's disease therapy. Mater Today Bio. 2025 Aug 4;34:102157.
                  </p>
                  <p>5. Gong B, Zhang W, Cong W, Gu Y, Ji W, Yin T, Zhou H, Hu H, Zhuang J, Luo Y, Liu Y, Gao J, Yin Y.
                    Systemic Administration of Neurotransmitter-Derived Lipidoids-PROTACs-DNA Nanocomplex Promotes Tau
                    Clearance and Cognitive Recovery for Alzheimer's Disease Therapy. Adv Healthc Mater. 2024 Jul
                  </p>
                  <p>6. Wang DD, Jiang LH, Zhang J, Chen X, Zhou HL, Zhong SL, Zhang HD. Androgen receptor expression
                    and clinical characteristics in breast cancer. World J Surg Oncol. 2024 Sep
                  </p>
                  <p>7. Wenquan Chen, Hao Li, Dandan Wang, Sujin Yang, Junchen Hou, Honglei Zhou, Jinhai Tang, Jian
                    Zhang,HJURP indicates poor prognosis of female breast cancer by promoting cell proliferation and
                    migration,Genes & Diseases,2023 Oct
                  </p>
                  <p>8. Shurui Xuan, Yuan Ma, Honglei Zhou, Shengwei Gu, Xin Yao, Xiaoning Zeng, The implication of
                    dendritic cells in lung diseases: Immunological role of Toll-like receptor 4, Genes & Diseases,2023
                    Apr
                  </p>
                  <p>9. Liang M, Fei Y, Wang Y, Chen W, Liu Z, Xu D, Shen H, Zhou H*, Tang J*. Integrative analysis of
                    the role of BOLA2B in human pan-cancer. Front Genet. 2023 Feb
                  </p>
                  <p>10. Yang K, Wang YL, Zhu Z, Cao XH, Liang MX, Xu D, Fei YJ, Yang SY, Zhou HL, Tang JH. CBX3 promotes
                    breast cancer progression and high level of CBX3 predicts poor prognosis in patients. Neoplasma.
                    2023 Feb
                  </p>
                  <p>11. Fang Z, Shen HY, Xu Q, Zhou HL, Li L, Yang SY, Zhu Z, Tang JH. PUS1 is a novel biomarker for
                    predicting poor outcomes and triple-negative status in breast cancer. Front Oncol. 2022 Nov
                  </p>
                  <p>12. Mogilyansky E, Clark P, Quann K, Zhou H, Londin E, Jing Y, Rigoutsos I. Post-transcriptional
                    Regulation of BRCA2 through Interactions with miR-19a and miR-19b. Front Genet. 2016 Aug
                  </p>
                  <p>13. Zhou H, Telonis AG, Jing Y, Xia NL, Biederman L, Jimbo M, Blanco F, Londin E, Brody JR,
                    Rigoutsos I. GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is
                    upregulated by gemcitabine with help from HuR. Cell Death Dis. 2016 Jul
                  </p>
                  <p>14. Zhou H, Rigoutsos I. MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells. RNA. 2014
                    Sep.
                  </p>

                </td>
              </tr>
            </tbody>
          </table>

          <table
            style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;">
            <tbody>
              <tr>
                <td style="padding:0px">
                  <br>
                  <p style="text-align:right;font-size:small;">
                    The design and code of this website is adapted from <a
                      href="https://github.com/jonbarron/jonbarron_website">Jon Barron's site.</a>
                  </p>
                </td>
              </tr>
            </tbody>
          </table>
        </td>
      </tr>
  </table>
</body>

</html>